Both in Biotechnology
Jasper Therapeutics vs Estrella Immunopharma
Over the past year JSPR returned −80.1% and ESLA returned −79.9%; their daily moves had a correlation of 0.10.
JSPR −80.1% ESLA −79.9%Growth of $1, one year, split-adjusted
| Metric | JSPR | ESLA |
|---|---|---|
| Price | $0.4999 | $0.4000 |
| Market cap | $16.6M | $17.4M |
| Today | +4.71% | +5.29% |
| 1 month | −17.1% | −20.4% |
| 6 months | −47.9% | −77.9% |
| Year to date | −72.7% | −74.4% |
| 1 year | −79.6% | −77.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $146.7K |
| Dividend yield | — | — |
| Volatility (60d) | 88.6% | 142.9% |
| Short % of float | 21.7% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).